:

Wei-Ting Chang1,2,3, Hui-Wen Lin4, Chin-Hsiu Liu3

  • 1School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University Kaohsiung 80424, Taiwan.

概括

免疫检查点抑制剂 (ICI) 在30天内增加心力衰竭和周心肌炎的风险,特别是在具有先前疾病的老年患者中. 这一发现突出了癌症治疗期间关键的心血管监测.